Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Endoscopy|November 30, 2018
Endoscopic ultrasound measurements for detection of residual disease after neoadjuvant chemoradiotherapy for esophageal cancerRuben D van der Bogt, Bo J Noordman, Kausilia K Krishnadath, et al.
BMJ Open|May 8, 2024
Peroperative administration of tranexamic acid in Roux-en-Y and one-anastomosis gastric bypass to reduce haemorrhage in patients with morbid obesity: protocol for randomised controlled trial (PATRY trial)Judith W H 't Hart, Bo J Noordman, Jeannine Palsgraaf-Huisbrink, et al.
Drugs|January 12, 2023
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface MalignanciesNiels A D Guchelaar, Bo J Noordman, Stijn L W Koolen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastasesNiels A D Guchelaar, Marion W Tops-Welten, Pieter C van der Sluis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 29, 2024
Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based StudyNiels A D Guchelaar, Bo J Noordman, Marion W Welten, et al.
International Journal of Cancer|October 17, 2022
Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO-studyMerel Hermus, Berend J van der Wilk, Rebecca T H Chang, et al.
Eclinicalmedicine|March 3, 2025
The prognostic value of peritoneal metastases in patients with gastric cancer: a nationwide population-based studyNiels A D Guchelaar, Micha J de Neijs, Bo J Noordman, et al.
Annals of Surgery|October 9, 2019
Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched StudyBerend J van der Wilk, Bo J Noordman, Lisanne K A Neijenhuis, et al.
The Lancet. Oncology|March 20, 2025
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialBerend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, et al.
The British Journal of Surgery|January 27, 2026
Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial)Sanjiv S G Gangaram Panday, Berend J van der Wilk, Ben M Eyck, et al.
Pageof 2